Ingegnere et al. have reported that electroporation-mediated transfer of plasmid encoding CCR7 increases the migration of CD19 CAR-NK cells in response to CCL19 and CCCL21 up to 6 times and increases their killing efficiency in CD19+ malignancies up to 5fold (Ingegnere et al., 2019). Here, CD19 is linked to cancer.